Physician profile
Thomas M Murphy
NPI 1144272931
$1,074.53
in general payments reported to CMS, 2019-2025
19 companies · $56.76 in 2025
The $56.76 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $802 · 2020: $162 · 2022: $21.43 · 2024: $32.92 · 2025: $56.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $212.70 | 2019-2025 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.93 | 2019-2020 | |
| Novo Nordisk INC | $90.40 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $89.56 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $82.87 | 2019-2020 | |
| Mylan Specialty L.P. | $61.80 | 2019-2020 | |
| Genentech USA, INC. | $57.31 | 2019 | |
| Lilly USA, LLC | $54.30 | 2019-2020 | |
| Grifols USA, LLC | $41.27 | 2019 | |
| Philips North America LLC | $41.13 | 2019 | |
| Pulmonx Corporation | $32.92 | 2024 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Insmed, INC. | $29.15 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $25.72 | 2019 | |
| Gilead Sciences, INC. | $17.91 | 2019 | |
| Sunovion Pharmaceuticals INC. | $16.34 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $16.25 | 2019 | |
| Amgen INC. | $15.12 | 2019 | |
| Tactile Systems Technology INC | $13.18 | 2019 | |
| Pfizer INC. | $12.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.